BCAL Diagnostics Limited (AU:BDX) has released an update.
BCAL Diagnostics Limited has reported a significant change in director’s interests, revealing that Director David Darling has acquired 35,880 ordinary shares through an on-market purchase valued at $4,485. The transaction has increased Darling’s total holdings in the company to the same number of shares, indicating a newfound direct financial stake in the company’s performance.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.
